The results from Soliton Inc's pivotal cellulite trial will be now be presented at the AAD 2020 Annual Meeting, to now be held virtually in the next 6-8 weeks, the company announces in a media release.
Sofwave Medical Ltd announces that the U.S. FDA has cleared it Sofwave’s SUPERB™ technology to be used for the short-term improvement in the appearance of cellulite.
Researchers have discovered a naturally occurring protein that could lead to new therapies for preventing excessive scarring in patients during wound healing.
SoftWave Tissue Regeneration Technologies announces its plan to embark on a 60-patient study for the treatment of cellulite.
Read More
Endo International plc announces it has received US Food and Drug Administration (FDA) approval of QWO (collagenase clostridium histolyticum-aaes) for the treatment of moderate to severe cellulite in the buttocks of adult women.
Read MoreUnder the terms of the agreement, Sanmina Corporation will manufacture Soliton’s RAP device and replaceable cartridges, Soliton announces.
Read More
The US Food and Drug Administration (FDA) has cleared a new indication statement that shows the benefits of the Cellfina System lasts for 5 years, an increase from the previous 3-year indication, Merz announces.
Read More
Endo International plc announces it has submitted a Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for collagenase clostridium histolyticum (CCH) for the treatment of cellulite in the buttocks.
Read More
Soliton Inc announces it will move forward with a pivotal cellulite trial after results from its Proof of Concept (POC) clinical trial revealed a 20% to 47% improvement in the cellulite severity score.
Read MoreThe Cellfina™ System will be available to physicians across the US in Fall 2015.
Read MoreThe new cellulite cure, a way for the jet set to keep their skin hydrated and more in June 2015 PSP Hot Stuff.
Read MoreWith a 94% patient-satisfaction rating at 1 year, Cellfina just may be the must-have cellulite treatment for summer 2015.
Read More